InvestorsHub Logo
Followers 35
Posts 182
Boards Moderated 0
Alias Born 05/03/2020

Re: JPsooner post# 300151

Saturday, 06/06/2020 1:03:18 AM

Saturday, June 06, 2020 1:03:18 AM

Post# of 403039
I think it's a fair assessment with $1.5b max with any pharma carrying the cost of clinical trials and commercialization of Bril without the phase II commencing yet. Bril will be fast-tracked for CV19.

$600mil now and another 900mil as contingent value rights (CVR). Any funding or grants plus PII will push the cash upfront and CVR higher. As of right now, getting a $1.5b cash only after funding and grant could happen too. TAGB is betting on Bril and Leo!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News